PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
- PMID: 17290298
- DOI: 10.1038/nri2036
PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Abstract
Dysregulated signal transduction in innate and adaptive immune cells is known to be associated with the development of various autoimmune and inflammatory diseases. Consequently, targeting intracellular signalling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs. Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signalling pathways that are known to have important roles in leukocytes. In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, we discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.
Similar articles
-
Phosphoinositide 3-kinase signalling in the vascular system.Cardiovasc Res. 2009 May 1;82(2):261-71. doi: 10.1093/cvr/cvn325. Epub 2008 Nov 26. Cardiovasc Res. 2009. PMID: 19038971 Review.
-
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.J Pharmacol Exp Ther. 2007 Apr;321(1):1-8. doi: 10.1124/jpet.106.111674. Epub 2006 Oct 4. J Pharmacol Exp Ther. 2007. PMID: 17021257 Review.
-
Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.Thromb Haemost. 2008 Feb;99(2):279-85. doi: 10.1160/TH07-10-0632. Thromb Haemost. 2008. PMID: 18278175 Review.
-
Cardiac regulation by phosphoinositide 3-kinases and PTEN.Cardiovasc Res. 2009 May 1;82(2):250-60. doi: 10.1093/cvr/cvp014. Epub 2009 Jan 15. Cardiovasc Res. 2009. PMID: 19147653 Review.
-
Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.Respirology. 2008 Nov;13(6):764-71. doi: 10.1111/j.1440-1843.2008.01369.x. Respirology. 2008. PMID: 18811876 Review.
Cited by
-
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin.BMC Pharmacol Toxicol. 2024 Oct 22;25(1):79. doi: 10.1186/s40360-024-00804-z. BMC Pharmacol Toxicol. 2024. PMID: 39439008 Free PMC article.
-
Yishen Tongbi decoction attenuates inflammation and bone destruction in rheumatoid arthritis by regulating JAK/STAT3/SOCS3 pathway.Front Immunol. 2024 Jun 20;15:1381802. doi: 10.3389/fimmu.2024.1381802. eCollection 2024. Front Immunol. 2024. PMID: 38966637 Free PMC article.
-
PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells.Nat Immunol. 2024 Aug;25(8):1422-1431. doi: 10.1038/s41590-024-01890-1. Epub 2024 Jul 3. Nat Immunol. 2024. PMID: 38961274
-
Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes.Arthritis Res Ther. 2024 Jun 12;26(1):120. doi: 10.1186/s13075-024-03351-4. Arthritis Res Ther. 2024. PMID: 38867295 Free PMC article.
-
6'-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice.Front Immunol. 2023 Dec 7;14:1264060. doi: 10.3389/fimmu.2023.1264060. eCollection 2023. Front Immunol. 2023. PMID: 38130726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases